Cardiol Therapeutics Inc Class A (US: CRDL) — Healthcare · Share Price, Chart & Market Data
About: Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Latest price: $1.40 (+2.94%)
CRDLCardiol Therapeutics Inc Class A
Loading watchlist status…
Trade CRDL now
Cardiol Therapeutics Inc Class A share price
CRDL price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 9:27 am GMT+0
CRDL price performance
-14.11%
5D
12%
1M
40.817%
YTD
29.63%
1Y
CRDL price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
US rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 9:27 am GMT+0
CRDL details
CRDL Market Signals